Sunday, January 2, 2022

Two studies provide good news for the antiviral drug remdesivir.


By BY GINA KOLATA from NYT Science https://ift.tt/31hp5jB
on
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)